194729-28-7

Upstream product

• 6006-82-2 3,4-methylenedioxyphenethyl alcohol 
• 194729-10-7 7,8-methylenedioxy-1-(4-nitrophenyl)-3,5-dihydro-2,3-benzodiazepin-4(4H)-one 
• 2861-28-1 1,3-benzodioxole-5-acetic acid 
• 194729-11-8 5-(4-nitrophenyl)-7H-1,3-dioxolo[4,5-h][2,3]benzodiazepine-8(9H)-thione 
• 194729-09-4 2-(4-nitro-benzoyl)-4,5-(methylenedioxy)-phenyl acetic acid 
• 53732-94-8 5-(4-Nitrophenyl)-1,3-dioxolo[4,5-g]-isochroman 
• 862457-87-2 (2,2-dimethoxy-ethyl)-[5-(4-nitro-phenyl)-7,9-dihydro-1,3-dioxa-6,7-diaza-cyclohepta[f]inden-8-ylidene]-amine 

Downstream Products

• 862457-91-8 C₁₈H₁₂Br₂N₄O₂ 
• 862457-88-3 C₁₈H₁₃N₃O₂ 
• 862457-90-7 8,9-dibromo-5-(4-nitrophenyl)-11H-1,3-dioxolo[4,5-h]imidazo[1,2-c][2,3]benzodiazepine 
• 194729-29-8 C₁₈H₁₄N₄O₂ 

Relevant academic research and scientific papers

Novel α-amino-3-hydroxy-5-methyl-4-isoxazole propionate (AMPA) receptor antagonists of 2,3-benzodiazepine type: Chemical synthesis, in vitro characterization, and in vivo prevention of acute neurodegeneration

Under pathophysiological conditions, α-amino-3-hydroxy-5-methyl-4- isoxazole propionate (AMPA) receptor activation is considered to play a key role in several disorders of the central nervous system. In the search for AMPA receptor antagonists, the synthe

CONDENSED 2,3-BENZODIAZEPINE DERIVATIVES AND THIER USE AS AMPA-RECEPTOR INHIBITORS

Compounds of formula I are described, their production and use in pharmaceutical agents.